Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2025-12-24 @ 11:18 PM
NCT ID:
NCT00893256
Eligibility Criteria:
Inclusion Criteria:
* Patients fulfilling DSMIV Criteria for Schizophrenia
* The patient should be drug naïve or drug free for one month (oral antipsychotic) or three months of parental antipsychotic
* Duration from onset \< 5 years
* Informed consent
Exclusion Criteria:
* Patient with any other current Axis I or Axis II comorbid disorders
* Comorbid substance abuse or dependence except nicotine or caffeine
* Presence of significant medical disorder such as epilepsy, uncontrolled hypertension and diabetes mellitus, thyroid disorder
* Patient who has not responded to adequate course of risperidone (with reference to dose and duration)
* Treatment-resistant schizophrenia defined as non-response to three different antipsychotics belonging to at least two different classes, one of which is an atypical agent and one of which is a depot neuroleptic
* Patient who has received ECT in past 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
17 Years
Maximum Age:
50 Years
Study:
NCT00893256
Study Brief:
Protocol Section:
NCT00893256